An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

An experimental treatment appears to delay Alzheimer's symptoms in some people genetically destined to get the disease in ...

The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

A recent trial on gantenerumab showed that the drug could reduce the risk of Alzheimer’s symptoms by 50% in pre-symptomatic ...

A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to remove amyloid plaques from the brain ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...

“Continuing to follow them on treatment may provide the best test of the amyloid hypothesis that the field can undertake and stands to provide critical evidence either for or against i ...